Target intelligence / Profile preview

Calponin-3 (CNN3)

Target
CNN3
Molecular classification
Actin-binding protein, Cytoskeletal regulatory protein, Other
01

Overview

Calponin-3 (CNN3) is an actin-binding regulatory protein encoded by the CNN3 gene in humans[1][6]. It consists of a conserved calponin homology (CH) domain, two actin-binding regions, and a variable C-terminus that distinguishes it from other calponin isoforms[1][5]. Calponin-3 is highly expressed in neural tissues (where it is involved in regulating actin cytoskeleton and neural plasticity), as well as in fibroblasts, embryonic trophoblasts, and myoblasts, where it negatively regulates cell fusion important for embryonic development and myogenesis[1][4][5]. In wound healing, it plays a role in fibroblast migration, stress fiber formation, and contractility[2][3]. Knockdown or loss of calponin-3 disrupts cytoskeletal organization, impairs cell migration, and is lethal in early development due to critical defects in neural tissue development[1][5]. Unlike typical receptors, enzymes, or druggable targets, calponin-3 is not considered a direct therapeutic target and there are no known drugs or specific clinical biomarkers associated with it. However, its regulatory role in processes like cell fusion and motility may have implications in developmental biology, fibrosis, and possibly regenerative medicine or neurodevelopmental disorders[1][4][5].

Other names
calponin 3acidic calponinh3/acidic calponinCNN3
02

Biological functions

Regulation of actin cytoskeletonCell motilityEmbryonic developmentMyogenesis (muscle cell fusion)Neural plasticityNegative regulation of cell fusion (trophoblasts, myoblasts)
03

Disease associations

Neurodevelopmental disorders (implied by knockout lethality and neural function)Wound healing and fibrosisMuscle development disorders (speculative; role in myogenesis)Other

Beyond the preview

Go deeper on Calponin-3 (CNN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calponin-3 (CNN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call